English Comprehension PYQs

Directions: Read the given passage carefully to answer the following questions.

Each question will have five alternatives as its answer. Choose the correct option as your answer.

In the realm of medical science, the administration of medications and treatments is a crucial process that directly impacts patient outcomes. Traditionally, the two most common methods of drug delivery have been through injections and oral capsules.

Each method has distinct advantages and disadvantages, and recent advancements in research, particularly from the Massachusetts Institute of Technology (MIT), are poised to revolutionise this aspect of healthcare. For many patients, the mere thought of needles can evoke a sense of dread and anxiety. This fear, known as needle phobia, is a significant barrier to effective medical treatment for a considerable portion of the population. Injections, although effective in delivering drugs quickly into the bloodstream, come with the disadvantages of pain, the risk of infection at the injection site, and the necessity for medical professionals to administer the medication. These factors contribute to decreased patient compliance and increased healthcare costs. On the other hand, oral capsules offer a more convenient and generally painless option, as they can be self-administered without the need for a healthcare provider. Capsules are particularly advantageous for their ease of use and non-invasive nature. However, they are not suitable for all types of medications. Many drugs degrade in the acidic environment of the stomach or are not absorbed efficiently in the gastrointestinal tract, making capsules an unreliable method for drugs requiring precise dosing. Recognising these challenges, researchers at MIT have been at the ___________ drug delivery technologies. One of their most notable advancements is a new capsule-based technology designed to administer insulin for patients with Type-1 diabetes. This groundbreaking innovation addresses several limitations associated with traditional methods of insulin delivery. Type-1 diabetes requires continual management of blood glucose levels through the administration of insulin. Historically, this has been achieved through regular injections, which can be burdensome and painful for patients. The MIT research team focused on creating a capsule that could deliver insulin effectively without the discomfort associated with needles. The technology involves a specially engineered capsule that houses a tiny, spring-loaded needle made of insulin. When the capsule reaches the stomach, the needle is injected directly into the stomach lining, painlessly delivering the insulin into the bloodstream. This method leverages the stomach's thick lining, which is less sensitive to pain than the skin, and ensures that the insulin is released in a controlled manner. The capsule's design ensures that the insulin remains stable in the stomach's acidic conditions and is protected until it is absorbed. This innovation holds the potential to transform the management of Type-1 diabetes, making treatment more accessible and less intimidating for patients. The pros of this new technology are evident. It reduces the pain and anxiety associated with needle injections, increases patient compliance, and eliminates the need for frequent doctor visits for insulin administration. Moreover, it opens the door to the oral delivery of other biologic drugs that currently require injections, such as certain cancer medications and vaccines. However, this new technology is not without its challenges and limitations. Ensuring the consistent production of these advanced capsules on a large scale is complex and may pose significant manufacturing challenges. Additionally, long-term studies are necessary to fully understand the capsule's effects on the stomach lining and its efficacy in various patient populations. Furthermore, the cost of developing and producing such sophisticated drug delivery systems might initially be higher than traditional methods, potentially making it less accessible to underprivileged communities.

Despite these potential obstacles, the ongoing research and development at MIT represent a significant leap forward in medical science. As technology progresses, the hope is that such innovations will become more cost-effective and widely available, ultimately improving the quality of life for millions of patients worldwide. The new capsule-based drug delivery system exemplifies how thoughtful, patient-centred medical advancements can overcome longstanding barriers in healthcare, offering a glimpse into a future where painful injections could be a distant memory.

Directions: Read the given passage carefully to answer the following questions.

Each question will have five alternatives as its answer. Choose the correct option as your answer.

In the realm of medical science, the administration of medications and treatments is a crucial process that directly impacts patient outcomes. Traditionally, the two most common methods of drug delivery have been through injections and oral capsules.

Each method has distinct advantages and disadvantages, and recent advancements in research, particularly from the Massachusetts Institute of Technology (MIT), are poised to revolutionise this aspect of healthcare. For many patients, the mere thought of needles can evoke a sense of dread and anxiety. This fear, known as needle phobia, is a significant barrier to effective medical treatment for a considerable portion of the population. Injections, although effective in delivering drugs quickly into the bloodstream, come with the disadvantages of pain, the risk of infection at the injection site, and the necessity for medical professionals to administer the medication. These factors contribute to decreased patient compliance and increased healthcare costs. On the other hand, oral capsules offer a more convenient and generally painless option, as they can be self-administered without the need for a healthcare provider. Capsules are particularly advantageous for their ease of use and non-invasive nature. However, they are not suitable for all types of medications. Many drugs degrade in the acidic environment of the stomach or are not absorbed efficiently in the gastrointestinal tract, making capsules an unreliable method for drugs requiring precise dosing. Recognising these challenges, researchers at MIT have been at the ___________ drug delivery technologies. One of their most notable advancements is a new capsule-based technology designed to administer insulin for patients with Type-1 diabetes. This groundbreaking innovation addresses several limitations associated with traditional methods of insulin delivery. Type-1 diabetes requires continual management of blood glucose levels through the administration of insulin. Historically, this has been achieved through regular injections, which can be burdensome and painful for patients. The MIT research team focused on creating a capsule that could deliver insulin effectively without the discomfort associated with needles. The technology involves a specially engineered capsule that houses a tiny, spring-loaded needle made of insulin. When the capsule reaches the stomach, the needle is injected directly into the stomach lining, painlessly delivering the insulin into the bloodstream. This method leverages the stomach's thick lining, which is less sensitive to pain than the skin, and ensures that the insulin is released in a controlled manner. The capsule's design ensures that the insulin remains stable in the stomach's acidic conditions and is protected until it is absorbed. This innovation holds the potential to transform the management of Type-1 diabetes, making treatment more accessible and less intimidating for patients. The pros of this new technology are evident. It reduces the pain and anxiety associated with needle injections, increases patient compliance, and eliminates the need for frequent doctor visits for insulin administration. Moreover, it opens the door to the oral delivery of other biologic drugs that currently require injections, such as certain cancer medications and vaccines. However, this new technology is not without its challenges and limitations. Ensuring the consistent production of these advanced capsules on a large scale is complex and may pose significant manufacturing challenges. Additionally, long-term studies are necessary to fully understand the capsule's effects on the stomach lining and its efficacy in various patient populations. Furthermore, the cost of developing and producing such sophisticated drug delivery systems might initially be higher than traditional methods, potentially making it less accessible to underprivileged communities.

Despite these potential obstacles, the ongoing research and development at MIT represent a significant leap forward in medical science. As technology progresses, the hope is that such innovations will become more cost-effective and widely available, ultimately improving the quality of life for millions of patients worldwide. The new capsule-based drug delivery system exemplifies how thoughtful, patient-centred medical advancements can overcome longstanding barriers in healthcare, offering a glimpse into a future where painful injections could be a distant memory.

Directions: Read the given passage carefully to answer the following questions.

Each question will have five alternatives as its answer. Choose the correct option as your answer.

In the realm of medical science, the administration of medications and treatments is a crucial process that directly impacts patient outcomes. Traditionally, the two most common methods of drug delivery have been through injections and oral capsules.

Each method has distinct advantages and disadvantages, and recent advancements in research, particularly from the Massachusetts Institute of Technology (MIT), are poised to revolutionise this aspect of healthcare. For many patients, the mere thought of needles can evoke a sense of dread and anxiety. This fear, known as needle phobia, is a significant barrier to effective medical treatment for a considerable portion of the population. Injections, although effective in delivering drugs quickly into the bloodstream, come with the disadvantages of pain, the risk of infection at the injection site, and the necessity for medical professionals to administer the medication. These factors contribute to decreased patient compliance and increased healthcare costs. On the other hand, oral capsules offer a more convenient and generally painless option, as they can be self-administered without the need for a healthcare provider. Capsules are particularly advantageous for their ease of use and non-invasive nature. However, they are not suitable for all types of medications. Many drugs degrade in the acidic environment of the stomach or are not absorbed efficiently in the gastrointestinal tract, making capsules an unreliable method for drugs requiring precise dosing. Recognising these challenges, researchers at MIT have been at the ___________ drug delivery technologies. One of their most notable advancements is a new capsule-based technology designed to administer insulin for patients with Type-1 diabetes. This groundbreaking innovation addresses several limitations associated with traditional methods of insulin delivery. Type-1 diabetes requires continual management of blood glucose levels through the administration of insulin. Historically, this has been achieved through regular injections, which can be burdensome and painful for patients. The MIT research team focused on creating a capsule that could deliver insulin effectively without the discomfort associated with needles. The technology involves a specially engineered capsule that houses a tiny, spring-loaded needle made of insulin. When the capsule reaches the stomach, the needle is injected directly into the stomach lining, painlessly delivering the insulin into the bloodstream. This method leverages the stomach's thick lining, which is less sensitive to pain than the skin, and ensures that the insulin is released in a controlled manner. The capsule's design ensures that the insulin remains stable in the stomach's acidic conditions and is protected until it is absorbed. This innovation holds the potential to transform the management of Type-1 diabetes, making treatment more accessible and less intimidating for patients. The pros of this new technology are evident. It reduces the pain and anxiety associated with needle injections, increases patient compliance, and eliminates the need for frequent doctor visits for insulin administration. Moreover, it opens the door to the oral delivery of other biologic drugs that currently require injections, such as certain cancer medications and vaccines. However, this new technology is not without its challenges and limitations. Ensuring the consistent production of these advanced capsules on a large scale is complex and may pose significant manufacturing challenges. Additionally, long-term studies are necessary to fully understand the capsule's effects on the stomach lining and its efficacy in various patient populations. Furthermore, the cost of developing and producing such sophisticated drug delivery systems might initially be higher than traditional methods, potentially making it less accessible to underprivileged communities.

Despite these potential obstacles, the ongoing research and development at MIT represent a significant leap forward in medical science. As technology progresses, the hope is that such innovations will become more cost-effective and widely available, ultimately improving the quality of life for millions of patients worldwide. The new capsule-based drug delivery system exemplifies how thoughtful, patient-centred medical advancements can overcome longstanding barriers in healthcare, offering a glimpse into a future where painful injections could be a distant memory.

Directions: Read the given passage carefully to answer the following questions.

Each question will have five alternatives as its answer. Choose the correct option as your answer.

In the realm of medical science, the administration of medications and treatments is a crucial process that directly impacts patient outcomes. Traditionally, the two most common methods of drug delivery have been through injections and oral capsules.

Each method has distinct advantages and disadvantages, and recent advancements in research, particularly from the Massachusetts Institute of Technology (MIT), are poised to revolutionise this aspect of healthcare. For many patients, the mere thought of needles can evoke a sense of dread and anxiety. This fear, known as needle phobia, is a significant barrier to effective medical treatment for a considerable portion of the population. Injections, although effective in delivering drugs quickly into the bloodstream, come with the disadvantages of pain, the risk of infection at the injection site, and the necessity for medical professionals to administer the medication. These factors contribute to decreased patient compliance and increased healthcare costs. On the other hand, oral capsules offer a more convenient and generally painless option, as they can be self-administered without the need for a healthcare provider. Capsules are particularly advantageous for their ease of use and non-invasive nature. However, they are not suitable for all types of medications. Many drugs degrade in the acidic environment of the stomach or are not absorbed efficiently in the gastrointestinal tract, making capsules an unreliable method for drugs requiring precise dosing. Recognising these challenges, researchers at MIT have been at the ___________ drug delivery technologies. One of their most notable advancements is a new capsule-based technology designed to administer insulin for patients with Type-1 diabetes. This groundbreaking innovation addresses several limitations associated with traditional methods of insulin delivery. Type-1 diabetes requires continual management of blood glucose levels through the administration of insulin. Historically, this has been achieved through regular injections, which can be burdensome and painful for patients. The MIT research team focused on creating a capsule that could deliver insulin effectively without the discomfort associated with needles. The technology involves a specially engineered capsule that houses a tiny, spring-loaded needle made of insulin. When the capsule reaches the stomach, the needle is injected directly into the stomach lining, painlessly delivering the insulin into the bloodstream. This method leverages the stomach's thick lining, which is less sensitive to pain than the skin, and ensures that the insulin is released in a controlled manner. The capsule's design ensures that the insulin remains stable in the stomach's acidic conditions and is protected until it is absorbed. This innovation holds the potential to transform the management of Type-1 diabetes, making treatment more accessible and less intimidating for patients. The pros of this new technology are evident. It reduces the pain and anxiety associated with needle injections, increases patient compliance, and eliminates the need for frequent doctor visits for insulin administration. Moreover, it opens the door to the oral delivery of other biologic drugs that currently require injections, such as certain cancer medications and vaccines. However, this new technology is not without its challenges and limitations. Ensuring the consistent production of these advanced capsules on a large scale is complex and may pose significant manufacturing challenges. Additionally, long-term studies are necessary to fully understand the capsule's effects on the stomach lining and its efficacy in various patient populations. Furthermore, the cost of developing and producing such sophisticated drug delivery systems might initially be higher than traditional methods, potentially making it less accessible to underprivileged communities.

Despite these potential obstacles, the ongoing research and development at MIT represent a significant leap forward in medical science. As technology progresses, the hope is that such innovations will become more cost-effective and widely available, ultimately improving the quality of life for millions of patients worldwide. The new capsule-based drug delivery system exemplifies how thoughtful, patient-centred medical advancements can overcome longstanding barriers in healthcare, offering a glimpse into a future where painful injections could be a distant memory.

Directions: Read the given passage carefully to answer the following questions.

Each question will have five alternatives as its answer. Choose the correct option as your answer.

In the realm of medical science, the administration of medications and treatments is a crucial process that directly impacts patient outcomes. Traditionally, the two most common methods of drug delivery have been through injections and oral capsules.

Each method has distinct advantages and disadvantages, and recent advancements in research, particularly from the Massachusetts Institute of Technology (MIT), are poised to revolutionise this aspect of healthcare. For many patients, the mere thought of needles can evoke a sense of dread and anxiety. This fear, known as needle phobia, is a significant barrier to effective medical treatment for a considerable portion of the population. Injections, although effective in delivering drugs quickly into the bloodstream, come with the disadvantages of pain, the risk of infection at the injection site, and the necessity for medical professionals to administer the medication. These factors contribute to decreased patient compliance and increased healthcare costs. On the other hand, oral capsules offer a more convenient and generally painless option, as they can be self-administered without the need for a healthcare provider. Capsules are particularly advantageous for their ease of use and non-invasive nature. However, they are not suitable for all types of medications. Many drugs degrade in the acidic environment of the stomach or are not absorbed efficiently in the gastrointestinal tract, making capsules an unreliable method for drugs requiring precise dosing. Recognising these challenges, researchers at MIT have been at the ___________ drug delivery technologies. One of their most notable advancements is a new capsule-based technology designed to administer insulin for patients with Type-1 diabetes. This groundbreaking innovation addresses several limitations associated with traditional methods of insulin delivery. Type-1 diabetes requires continual management of blood glucose levels through the administration of insulin. Historically, this has been achieved through regular injections, which can be burdensome and painful for patients. The MIT research team focused on creating a capsule that could deliver insulin effectively without the discomfort associated with needles. The technology involves a specially engineered capsule that houses a tiny, spring-loaded needle made of insulin. When the capsule reaches the stomach, the needle is injected directly into the stomach lining, painlessly delivering the insulin into the bloodstream. This method leverages the stomach's thick lining, which is less sensitive to pain than the skin, and ensures that the insulin is released in a controlled manner. The capsule's design ensures that the insulin remains stable in the stomach's acidic conditions and is protected until it is absorbed. This innovation holds the potential to transform the management of Type-1 diabetes, making treatment more accessible and less intimidating for patients. The pros of this new technology are evident. It reduces the pain and anxiety associated with needle injections, increases patient compliance, and eliminates the need for frequent doctor visits for insulin administration. Moreover, it opens the door to the oral delivery of other biologic drugs that currently require injections, such as certain cancer medications and vaccines. However, this new technology is not without its challenges and limitations. Ensuring the consistent production of these advanced capsules on a large scale is complex and may pose significant manufacturing challenges. Additionally, long-term studies are necessary to fully understand the capsule's effects on the stomach lining and its efficacy in various patient populations. Furthermore, the cost of developing and producing such sophisticated drug delivery systems might initially be higher than traditional methods, potentially making it less accessible to underprivileged communities.

Despite these potential obstacles, the ongoing research and development at MIT represent a significant leap forward in medical science. As technology progresses, the hope is that such innovations will become more cost-effective and widely available, ultimately improving the quality of life for millions of patients worldwide. The new capsule-based drug delivery system exemplifies how thoughtful, patient-centred medical advancements can overcome longstanding barriers in healthcare, offering a glimpse into a future where painful injections could be a distant memory.

Directions: Read the given passage carefully to answer the following questions.

Each question will have five alternatives as its answer. Choose the correct option as your answer.

In the realm of medical science, the administration of medications and treatments is a crucial process that directly impacts patient outcomes. Traditionally, the two most common methods of drug delivery have been through injections and oral capsules.

Each method has distinct advantages and disadvantages, and recent advancements in research, particularly from the Massachusetts Institute of Technology (MIT), are poised to revolutionise this aspect of healthcare. For many patients, the mere thought of needles can evoke a sense of dread and anxiety. This fear, known as needle phobia, is a significant barrier to effective medical treatment for a considerable portion of the population. Injections, although effective in delivering drugs quickly into the bloodstream, come with the disadvantages of pain, the risk of infection at the injection site, and the necessity for medical professionals to administer the medication. These factors contribute to decreased patient compliance and increased healthcare costs. On the other hand, oral capsules offer a more convenient and generally painless option, as they can be self-administered without the need for a healthcare provider. Capsules are particularly advantageous for their ease of use and non-invasive nature. However, they are not suitable for all types of medications. Many drugs degrade in the acidic environment of the stomach or are not absorbed efficiently in the gastrointestinal tract, making capsules an unreliable method for drugs requiring precise dosing. Recognising these challenges, researchers at MIT have been at the ___________ drug delivery technologies. One of their most notable advancements is a new capsule-based technology designed to administer insulin for patients with Type-1 diabetes. This groundbreaking innovation addresses several limitations associated with traditional methods of insulin delivery. Type-1 diabetes requires continual management of blood glucose levels through the administration of insulin. Historically, this has been achieved through regular injections, which can be burdensome and painful for patients. The MIT research team focused on creating a capsule that could deliver insulin effectively without the discomfort associated with needles. The technology involves a specially engineered capsule that houses a tiny, spring-loaded needle made of insulin. When the capsule reaches the stomach, the needle is injected directly into the stomach lining, painlessly delivering the insulin into the bloodstream. This method leverages the stomach's thick lining, which is less sensitive to pain than the skin, and ensures that the insulin is released in a controlled manner. The capsule's design ensures that the insulin remains stable in the stomach's acidic conditions and is protected until it is absorbed. This innovation holds the potential to transform the management of Type-1 diabetes, making treatment more accessible and less intimidating for patients. The pros of this new technology are evident. It reduces the pain and anxiety associated with needle injections, increases patient compliance, and eliminates the need for frequent doctor visits for insulin administration. Moreover, it opens the door to the oral delivery of other biologic drugs that currently require injections, such as certain cancer medications and vaccines. However, this new technology is not without its challenges and limitations. Ensuring the consistent production of these advanced capsules on a large scale is complex and may pose significant manufacturing challenges. Additionally, long-term studies are necessary to fully understand the capsule's effects on the stomach lining and its efficacy in various patient populations. Furthermore, the cost of developing and producing such sophisticated drug delivery systems might initially be higher than traditional methods, potentially making it less accessible to underprivileged communities.

Despite these potential obstacles, the ongoing research and development at MIT represent a significant leap forward in medical science. As technology progresses, the hope is that such innovations will become more cost-effective and widely available, ultimately improving the quality of life for millions of patients worldwide. The new capsule-based drug delivery system exemplifies how thoughtful, patient-centred medical advancements can overcome longstanding barriers in healthcare, offering a glimpse into a future where painful injections could be a distant memory.

Directions: Read the given passage carefully to answer the following questions.

Each question will have five alternatives as its answer. Choose the correct option as your answer.

In the realm of medical science, the administration of medications and treatments is a crucial process that directly impacts patient outcomes. Traditionally, the two most common methods of drug delivery have been through injections and oral capsules.

Each method has distinct advantages and disadvantages, and recent advancements in research, particularly from the Massachusetts Institute of Technology (MIT), are poised to revolutionise this aspect of healthcare. For many patients, the mere thought of needles can evoke a sense of dread and anxiety. This fear, known as needle phobia, is a significant barrier to effective medical treatment for a considerable portion of the population. Injections, although effective in delivering drugs quickly into the bloodstream, come with the disadvantages of pain, the risk of infection at the injection site, and the necessity for medical professionals to administer the medication. These factors contribute to decreased patient compliance and increased healthcare costs. On the other hand, oral capsules offer a more convenient and generally painless option, as they can be self-administered without the need for a healthcare provider. Capsules are particularly advantageous for their ease of use and non-invasive nature. However, they are not suitable for all types of medications. Many drugs degrade in the acidic environment of the stomach or are not absorbed efficiently in the gastrointestinal tract, making capsules an unreliable method for drugs requiring precise dosing. Recognising these challenges, researchers at MIT have been at the ___________ drug delivery technologies. One of their most notable advancements is a new capsule-based technology designed to administer insulin for patients with Type-1 diabetes. This groundbreaking innovation addresses several limitations associated with traditional methods of insulin delivery. Type-1 diabetes requires continual management of blood glucose levels through the administration of insulin. Historically, this has been achieved through regular injections, which can be burdensome and painful for patients. The MIT research team focused on creating a capsule that could deliver insulin effectively without the discomfort associated with needles. The technology involves a specially engineered capsule that houses a tiny, spring-loaded needle made of insulin. When the capsule reaches the stomach, the needle is injected directly into the stomach lining, painlessly delivering the insulin into the bloodstream. This method leverages the stomach's thick lining, which is less sensitive to pain than the skin, and ensures that the insulin is released in a controlled manner. The capsule's design ensures that the insulin remains stable in the stomach's acidic conditions and is protected until it is absorbed. This innovation holds the potential to transform the management of Type-1 diabetes, making treatment more accessible and less intimidating for patients. The pros of this new technology are evident. It reduces the pain and anxiety associated with needle injections, increases patient compliance, and eliminates the need for frequent doctor visits for insulin administration. Moreover, it opens the door to the oral delivery of other biologic drugs that currently require injections, such as certain cancer medications and vaccines. However, this new technology is not without its challenges and limitations. Ensuring the consistent production of these advanced capsules on a large scale is complex and may pose significant manufacturing challenges. Additionally, long-term studies are necessary to fully understand the capsule's effects on the stomach lining and its efficacy in various patient populations. Furthermore, the cost of developing and producing such sophisticated drug delivery systems might initially be higher than traditional methods, potentially making it less accessible to underprivileged communities.

Despite these potential obstacles, the ongoing research and development at MIT represent a significant leap forward in medical science. As technology progresses, the hope is that such innovations will become more cost-effective and widely available, ultimately improving the quality of life for millions of patients worldwide. The new capsule-based drug delivery system exemplifies how thoughtful, patient-centred medical advancements can overcome longstanding barriers in healthcare, offering a glimpse into a future where painful injections could be a distant memory.

Directions: Read the given passage carefully to answer the following questions.

Each question will have five alternatives as its answer. Choose the correct option as your answer.

In the realm of medical science, the administration of medications and treatments is a crucial process that directly impacts patient outcomes. Traditionally, the two most common methods of drug delivery have been through injections and oral capsules.

Each method has distinct advantages and disadvantages, and recent advancements in research, particularly from the Massachusetts Institute of Technology (MIT), are poised to revolutionise this aspect of healthcare. For many patients, the mere thought of needles can evoke a sense of dread and anxiety. This fear, known as needle phobia, is a significant barrier to effective medical treatment for a considerable portion of the population. Injections, although effective in delivering drugs quickly into the bloodstream, come with the disadvantages of pain, the risk of infection at the injection site, and the necessity for medical professionals to administer the medication. These factors contribute to decreased patient compliance and increased healthcare costs. On the other hand, oral capsules offer a more convenient and generally painless option, as they can be self-administered without the need for a healthcare provider. Capsules are particularly advantageous for their ease of use and non-invasive nature. However, they are not suitable for all types of medications. Many drugs degrade in the acidic environment of the stomach or are not absorbed efficiently in the gastrointestinal tract, making capsules an unreliable method for drugs requiring precise dosing. Recognising these challenges, researchers at MIT have been at the ___________ drug delivery technologies. One of their most notable advancements is a new capsule-based technology designed to administer insulin for patients with Type-1 diabetes. This groundbreaking innovation addresses several limitations associated with traditional methods of insulin delivery. Type-1 diabetes requires continual management of blood glucose levels through the administration of insulin. Historically, this has been achieved through regular injections, which can be burdensome and painful for patients. The MIT research team focused on creating a capsule that could deliver insulin effectively without the discomfort associated with needles. The technology involves a specially engineered capsule that houses a tiny, spring-loaded needle made of insulin. When the capsule reaches the stomach, the needle is injected directly into the stomach lining, painlessly delivering the insulin into the bloodstream. This method leverages the stomach's thick lining, which is less sensitive to pain than the skin, and ensures that the insulin is released in a controlled manner. The capsule's design ensures that the insulin remains stable in the stomach's acidic conditions and is protected until it is absorbed. This innovation holds the potential to transform the management of Type-1 diabetes, making treatment more accessible and less intimidating for patients. The pros of this new technology are evident. It reduces the pain and anxiety associated with needle injections, increases patient compliance, and eliminates the need for frequent doctor visits for insulin administration. Moreover, it opens the door to the oral delivery of other biologic drugs that currently require injections, such as certain cancer medications and vaccines. However, this new technology is not without its challenges and limitations. Ensuring the consistent production of these advanced capsules on a large scale is complex and may pose significant manufacturing challenges. Additionally, long-term studies are necessary to fully understand the capsule's effects on the stomach lining and its efficacy in various patient populations. Furthermore, the cost of developing and producing such sophisticated drug delivery systems might initially be higher than traditional methods, potentially making it less accessible to underprivileged communities.

Despite these potential obstacles, the ongoing research and development at MIT represent a significant leap forward in medical science. As technology progresses, the hope is that such innovations will become more cost-effective and widely available, ultimately improving the quality of life for millions of patients worldwide. The new capsule-based drug delivery system exemplifies how thoughtful, patient-centred medical advancements can overcome longstanding barriers in healthcare, offering a glimpse into a future where painful injections could be a distant memory.

Directions: Read the given passage carefully to answer the following questions.

Each question will have five alternatives as its answer. Choose the correct option as your answer.

In the realm of medical science, the administration of medications and treatments is a crucial process that directly impacts patient outcomes. Traditionally, the two most common methods of drug delivery have been through injections and oral capsules.

Each method has distinct advantages and disadvantages, and recent advancements in research, particularly from the Massachusetts Institute of Technology (MIT), are poised to revolutionise this aspect of healthcare. For many patients, the mere thought of needles can evoke a sense of dread and anxiety. This fear, known as needle phobia, is a significant barrier to effective medical treatment for a considerable portion of the population. Injections, although effective in delivering drugs quickly into the bloodstream, come with the disadvantages of pain, the risk of infection at the injection site, and the necessity for medical professionals to administer the medication. These factors contribute to decreased patient compliance and increased healthcare costs. On the other hand, oral capsules offer a more convenient and generally painless option, as they can be self-administered without the need for a healthcare provider. Capsules are particularly advantageous for their ease of use and non-invasive nature. However, they are not suitable for all types of medications. Many drugs degrade in the acidic environment of the stomach or are not absorbed efficiently in the gastrointestinal tract, making capsules an unreliable method for drugs requiring precise dosing. Recognising these challenges, researchers at MIT have been at the ___________ drug delivery technologies. One of their most notable advancements is a new capsule-based technology designed to administer insulin for patients with Type-1 diabetes. This groundbreaking innovation addresses several limitations associated with traditional methods of insulin delivery. Type-1 diabetes requires continual management of blood glucose levels through the administration of insulin. Historically, this has been achieved through regular injections, which can be burdensome and painful for patients. The MIT research team focused on creating a capsule that could deliver insulin effectively without the discomfort associated with needles. The technology involves a specially engineered capsule that houses a tiny, spring-loaded needle made of insulin. When the capsule reaches the stomach, the needle is injected directly into the stomach lining, painlessly delivering the insulin into the bloodstream. This method leverages the stomach's thick lining, which is less sensitive to pain than the skin, and ensures that the insulin is released in a controlled manner. The capsule's design ensures that the insulin remains stable in the stomach's acidic conditions and is protected until it is absorbed. This innovation holds the potential to transform the management of Type-1 diabetes, making treatment more accessible and less intimidating for patients. The pros of this new technology are evident. It reduces the pain and anxiety associated with needle injections, increases patient compliance, and eliminates the need for frequent doctor visits for insulin administration. Moreover, it opens the door to the oral delivery of other biologic drugs that currently require injections, such as certain cancer medications and vaccines. However, this new technology is not without its challenges and limitations. Ensuring the consistent production of these advanced capsules on a large scale is complex and may pose significant manufacturing challenges. Additionally, long-term studies are necessary to fully understand the capsule's effects on the stomach lining and its efficacy in various patient populations. Furthermore, the cost of developing and producing such sophisticated drug delivery systems might initially be higher than traditional methods, potentially making it less accessible to underprivileged communities.

Despite these potential obstacles, the ongoing research and development at MIT represent a significant leap forward in medical science. As technology progresses, the hope is that such innovations will become more cost-effective and widely available, ultimately improving the quality of life for millions of patients worldwide. The new capsule-based drug delivery system exemplifies how thoughtful, patient-centred medical advancements can overcome longstanding barriers in healthcare, offering a glimpse into a future where painful injections could be a distant memory.

Directions: Read the given passage carefully to answer the following questions.

Each question will have five alternatives as its answer. Choose the correct option as your answer.

The landscape of employment has undergone significant transformations in recent years, particularly in the aftermath of the COVID-19 pandemic. Both the United States and the United Kingdom have witnessed profound shifts in employment patterns as individuals and organisations adapt to a new normal. Remote work, once a rare perk, has become a standard arrangement for many white-collar jobs. In the US, this has led to an unparalleled embrace of Work-From-Home (WFH) policies, allowing employees to perform their duties from virtually any location. The UK has mirrored this trend, with hybrid work models becoming increasingly popular. Companies have realised the potential for cost savings on office space and the benefits of a more flexible workforce. However, this move towards virtual working environments has also highlighted challenges related to maintaining corporate culture, employee engagement, and productivity. As businesses navigate these new dynamics, they are continuously refining their approaches to create sustainable and effective work models for the future. An in-depth survey conducted recently sheds light on the influence of an ageing population and the growing need for family care in the workforce. This survey encompassed a diverse group of respondents, spanning various industries and age groups, and revealed compelling insights. One of the most prominent findings was the significant impact of the ageing workforce on employment trends. With a larger proportion of the workforce nearing retirement age, businesses are facing a potential skills gap. Many older employees possess critical institutional knowledge and expertise, and their retirement could lead to a loss of valuable skills and experience. This scenario is prompting organisations to devise strategies for knowledge transfer and mentorship programmes to bridge the gap between outgoing and incoming employees. Additionally, the survey highlighted the increasing family care responsibilities shouldered by many workers, particularly those in the 'sandwich generation'—individuals who are simultaneously caring for their ageing parents and their own children. These dual responsibilities often require flexible working arrangements to balance professional and personal obligations. Companies that recognise and accommodate these needs are more likely to retain and attract talent. The importance of providing support for family care, such as flexible hours, remote work options, and enhanced family leave policies, was underscored as a critical factor in employee satisfaction and retention.

Job creation, meanwhile, continues to be a focal point of economic recovery efforts. The pandemic-induced recession prompted substantial job losses, but recent trends suggest a positive trajectory. The demand for certain job roles has surged, particularly in healthcare, technology, and logistics. Healthcare professionals, for instance, have seen a marked increase in demand due to ongoing public health concerns and an ageing population. The tech industry, driven by the need for digital transformation, continues to grow, creating jobs in software development, cybersecurity, and data analysis. Logistics and e-commerce have also boomed, with companies investing heavily in warehousing and distribution infrastructure to meet the higher consumer demand for online shopping. Overall, the employment landscape in the US is marked by a delicate balance of adapting to new work preferences, addressing the challenges posed by an ageing workforce, and capitalising on job creation opportunities in emerging sectors. Policymakers, employers, and employees alike must navigate these trends thoughtfully to foster a resilient and dynamic workforce capable of thriving in a post-pandemic world. As we move forward, the ability to adapt to these evolving trends will determine the success and stability of the job market in the coming years.

Directions: Read the given passage carefully to answer the following questions.

Each question will have five alternatives as its answer. Choose the correct option as your answer.

The landscape of employment has undergone significant transformations in recent years, particularly in the aftermath of the COVID-19 pandemic. Both the United States and the United Kingdom have witnessed profound shifts in employment patterns as individuals and organisations adapt to a new normal. Remote work, once a rare perk, has become a standard arrangement for many white-collar jobs. In the US, this has led to an unparalleled embrace of Work-From-Home (WFH) policies, allowing employees to perform their duties from virtually any location. The UK has mirrored this trend, with hybrid work models becoming increasingly popular. Companies have realised the potential for cost savings on office space and the benefits of a more flexible workforce. However, this move towards virtual working environments has also highlighted challenges related to maintaining corporate culture, employee engagement, and productivity. As businesses navigate these new dynamics, they are continuously refining their approaches to create sustainable and effective work models for the future. An in-depth survey conducted recently sheds light on the influence of an ageing population and the growing need for family care in the workforce. This survey encompassed a diverse group of respondents, spanning various industries and age groups, and revealed compelling insights. One of the most prominent findings was the significant impact of the ageing workforce on employment trends. With a larger proportion of the workforce nearing retirement age, businesses are facing a potential skills gap. Many older employees possess critical institutional knowledge and expertise, and their retirement could lead to a loss of valuable skills and experience. This scenario is prompting organisations to devise strategies for knowledge transfer and mentorship programmes to bridge the gap between outgoing and incoming employees. Additionally, the survey highlighted the increasing family care responsibilities shouldered by many workers, particularly those in the 'sandwich generation'—individuals who are simultaneously caring for their ageing parents and their own children. These dual responsibilities often require flexible working arrangements to balance professional and personal obligations. Companies that recognise and accommodate these needs are more likely to retain and attract talent. The importance of providing support for family care, such as flexible hours, remote work options, and enhanced family leave policies, was underscored as a critical factor in employee satisfaction and retention.

Job creation, meanwhile, continues to be a focal point of economic recovery efforts. The pandemic-induced recession prompted substantial job losses, but recent trends suggest a positive trajectory. The demand for certain job roles has surged, particularly in healthcare, technology, and logistics. Healthcare professionals, for instance, have seen a marked increase in demand due to ongoing public health concerns and an ageing population. The tech industry, driven by the need for digital transformation, continues to grow, creating jobs in software development, cybersecurity, and data analysis. Logistics and e-commerce have also boomed, with companies investing heavily in warehousing and distribution infrastructure to meet the higher consumer demand for online shopping. Overall, the employment landscape in the US is marked by a delicate balance of adapting to new work preferences, addressing the challenges posed by an ageing workforce, and capitalising on job creation opportunities in emerging sectors. Policymakers, employers, and employees alike must navigate these trends thoughtfully to foster a resilient and dynamic workforce capable of thriving in a post-pandemic world. As we move forward, the ability to adapt to these evolving trends will determine the success and stability of the job market in the coming years.

Directions: Read the given passage carefully to answer the following questions.

Each question will have five alternatives as its answer. Choose the correct option as your answer.

The landscape of employment has undergone significant transformations in recent years, particularly in the aftermath of the COVID-19 pandemic. Both the United States and the United Kingdom have witnessed profound shifts in employment patterns as individuals and organisations adapt to a new normal. Remote work, once a rare perk, has become a standard arrangement for many white-collar jobs. In the US, this has led to an unparalleled embrace of Work-From-Home (WFH) policies, allowing employees to perform their duties from virtually any location. The UK has mirrored this trend, with hybrid work models becoming increasingly popular. Companies have realised the potential for cost savings on office space and the benefits of a more flexible workforce. However, this move towards virtual working environments has also highlighted challenges related to maintaining corporate culture, employee engagement, and productivity. As businesses navigate these new dynamics, they are continuously refining their approaches to create sustainable and effective work models for the future. An in-depth survey conducted recently sheds light on the influence of an ageing population and the growing need for family care in the workforce. This survey encompassed a diverse group of respondents, spanning various industries and age groups, and revealed compelling insights. One of the most prominent findings was the significant impact of the ageing workforce on employment trends. With a larger proportion of the workforce nearing retirement age, businesses are facing a potential skills gap. Many older employees possess critical institutional knowledge and expertise, and their retirement could lead to a loss of valuable skills and experience. This scenario is prompting organisations to devise strategies for knowledge transfer and mentorship programmes to bridge the gap between outgoing and incoming employees. Additionally, the survey highlighted the increasing family care responsibilities shouldered by many workers, particularly those in the 'sandwich generation'—individuals who are simultaneously caring for their ageing parents and their own children. These dual responsibilities often require flexible working arrangements to balance professional and personal obligations. Companies that recognise and accommodate these needs are more likely to retain and attract talent. The importance of providing support for family care, such as flexible hours, remote work options, and enhanced family leave policies, was underscored as a critical factor in employee satisfaction and retention.

Job creation, meanwhile, continues to be a focal point of economic recovery efforts. The pandemic-induced recession prompted substantial job losses, but recent trends suggest a positive trajectory. The demand for certain job roles has surged, particularly in healthcare, technology, and logistics. Healthcare professionals, for instance, have seen a marked increase in demand due to ongoing public health concerns and an ageing population. The tech industry, driven by the need for digital transformation, continues to grow, creating jobs in software development, cybersecurity, and data analysis. Logistics and e-commerce have also boomed, with companies investing heavily in warehousing and distribution infrastructure to meet the higher consumer demand for online shopping. Overall, the employment landscape in the US is marked by a delicate balance of adapting to new work preferences, addressing the challenges posed by an ageing workforce, and capitalising on job creation opportunities in emerging sectors. Policymakers, employers, and employees alike must navigate these trends thoughtfully to foster a resilient and dynamic workforce capable of thriving in a post-pandemic world. As we move forward, the ability to adapt to these evolving trends will determine the success and stability of the job market in the coming years.

Directions: Read the given passage carefully to answer the following questions.

Each question will have five alternatives as its answer. Choose the correct option as your answer.

The landscape of employment has undergone significant transformations in recent years, particularly in the aftermath of the COVID-19 pandemic. Both the United States and the United Kingdom have witnessed profound shifts in employment patterns as individuals and organisations adapt to a new normal. Remote work, once a rare perk, has become a standard arrangement for many white-collar jobs. In the US, this has led to an unparalleled embrace of Work-From-Home (WFH) policies, allowing employees to perform their duties from virtually any location. The UK has mirrored this trend, with hybrid work models becoming increasingly popular. Companies have realised the potential for cost savings on office space and the benefits of a more flexible workforce. However, this move towards virtual working environments has also highlighted challenges related to maintaining corporate culture, employee engagement, and productivity. As businesses navigate these new dynamics, they are continuously refining their approaches to create sustainable and effective work models for the future. An in-depth survey conducted recently sheds light on the influence of an ageing population and the growing need for family care in the workforce. This survey encompassed a diverse group of respondents, spanning various industries and age groups, and revealed compelling insights. One of the most prominent findings was the significant impact of the ageing workforce on employment trends. With a larger proportion of the workforce nearing retirement age, businesses are facing a potential skills gap. Many older employees possess critical institutional knowledge and expertise, and their retirement could lead to a loss of valuable skills and experience. This scenario is prompting organisations to devise strategies for knowledge transfer and mentorship programmes to bridge the gap between outgoing and incoming employees. Additionally, the survey highlighted the increasing family care responsibilities shouldered by many workers, particularly those in the 'sandwich generation'—individuals who are simultaneously caring for their ageing parents and their own children. These dual responsibilities often require flexible working arrangements to balance professional and personal obligations. Companies that recognise and accommodate these needs are more likely to retain and attract talent. The importance of providing support for family care, such as flexible hours, remote work options, and enhanced family leave policies, was underscored as a critical factor in employee satisfaction and retention.

Job creation, meanwhile, continues to be a focal point of economic recovery efforts. The pandemic-induced recession prompted substantial job losses, but recent trends suggest a positive trajectory. The demand for certain job roles has surged, particularly in healthcare, technology, and logistics. Healthcare professionals, for instance, have seen a marked increase in demand due to ongoing public health concerns and an ageing population. The tech industry, driven by the need for digital transformation, continues to grow, creating jobs in software development, cybersecurity, and data analysis. Logistics and e-commerce have also boomed, with companies investing heavily in warehousing and distribution infrastructure to meet the higher consumer demand for online shopping. Overall, the employment landscape in the US is marked by a delicate balance of adapting to new work preferences, addressing the challenges posed by an ageing workforce, and capitalising on job creation opportunities in emerging sectors. Policymakers, employers, and employees alike must navigate these trends thoughtfully to foster a resilient and dynamic workforce capable of thriving in a post-pandemic world. As we move forward, the ability to adapt to these evolving trends will determine the success and stability of the job market in the coming years.

Directions: Read the given passage carefully to answer the following questions.

Each question will have five alternatives as its answer. Choose the correct option as your answer.

The landscape of employment has undergone significant transformations in recent years, particularly in the aftermath of the COVID-19 pandemic. Both the United States and the United Kingdom have witnessed profound shifts in employment patterns as individuals and organisations adapt to a new normal. Remote work, once a rare perk, has become a standard arrangement for many white-collar jobs. In the US, this has led to an unparalleled embrace of Work-From-Home (WFH) policies, allowing employees to perform their duties from virtually any location. The UK has mirrored this trend, with hybrid work models becoming increasingly popular. Companies have realised the potential for cost savings on office space and the benefits of a more flexible workforce. However, this move towards virtual working environments has also highlighted challenges related to maintaining corporate culture, employee engagement, and productivity. As businesses navigate these new dynamics, they are continuously refining their approaches to create sustainable and effective work models for the future. An in-depth survey conducted recently sheds light on the influence of an ageing population and the growing need for family care in the workforce. This survey encompassed a diverse group of respondents, spanning various industries and age groups, and revealed compelling insights. One of the most prominent findings was the significant impact of the ageing workforce on employment trends. With a larger proportion of the workforce nearing retirement age, businesses are facing a potential skills gap. Many older employees possess critical institutional knowledge and expertise, and their retirement could lead to a loss of valuable skills and experience. This scenario is prompting organisations to devise strategies for knowledge transfer and mentorship programmes to bridge the gap between outgoing and incoming employees. Additionally, the survey highlighted the increasing family care responsibilities shouldered by many workers, particularly those in the 'sandwich generation'—individuals who are simultaneously caring for their ageing parents and their own children. These dual responsibilities often require flexible working arrangements to balance professional and personal obligations. Companies that recognise and accommodate these needs are more likely to retain and attract talent. The importance of providing support for family care, such as flexible hours, remote work options, and enhanced family leave policies, was underscored as a critical factor in employee satisfaction and retention.

Job creation, meanwhile, continues to be a focal point of economic recovery efforts. The pandemic-induced recession prompted substantial job losses, but recent trends suggest a positive trajectory. The demand for certain job roles has surged, particularly in healthcare, technology, and logistics. Healthcare professionals, for instance, have seen a marked increase in demand due to ongoing public health concerns and an ageing population. The tech industry, driven by the need for digital transformation, continues to grow, creating jobs in software development, cybersecurity, and data analysis. Logistics and e-commerce have also boomed, with companies investing heavily in warehousing and distribution infrastructure to meet the higher consumer demand for online shopping. Overall, the employment landscape in the US is marked by a delicate balance of adapting to new work preferences, addressing the challenges posed by an ageing workforce, and capitalising on job creation opportunities in emerging sectors. Policymakers, employers, and employees alike must navigate these trends thoughtfully to foster a resilient and dynamic workforce capable of thriving in a post-pandemic world. As we move forward, the ability to adapt to these evolving trends will determine the success and stability of the job market in the coming years.

Directions: Read the given passage carefully to answer the following questions.

Each question will have five alternatives as its answer. Choose the correct option as your answer.

The landscape of employment has undergone significant transformations in recent years, particularly in the aftermath of the COVID-19 pandemic. Both the United States and the United Kingdom have witnessed profound shifts in employment patterns as individuals and organisations adapt to a new normal. Remote work, once a rare perk, has become a standard arrangement for many white-collar jobs. In the US, this has led to an unparalleled embrace of Work-From-Home (WFH) policies, allowing employees to perform their duties from virtually any location. The UK has mirrored this trend, with hybrid work models becoming increasingly popular. Companies have realised the potential for cost savings on office space and the benefits of a more flexible workforce. However, this move towards virtual working environments has also highlighted challenges related to maintaining corporate culture, employee engagement, and productivity. As businesses navigate these new dynamics, they are continuously refining their approaches to create sustainable and effective work models for the future. An in-depth survey conducted recently sheds light on the influence of an ageing population and the growing need for family care in the workforce. This survey encompassed a diverse group of respondents, spanning various industries and age groups, and revealed compelling insights. One of the most prominent findings was the significant impact of the ageing workforce on employment trends. With a larger proportion of the workforce nearing retirement age, businesses are facing a potential skills gap. Many older employees possess critical institutional knowledge and expertise, and their retirement could lead to a loss of valuable skills and experience. This scenario is prompting organisations to devise strategies for knowledge transfer and mentorship programmes to bridge the gap between outgoing and incoming employees. Additionally, the survey highlighted the increasing family care responsibilities shouldered by many workers, particularly those in the 'sandwich generation'—individuals who are simultaneously caring for their ageing parents and their own children. These dual responsibilities often require flexible working arrangements to balance professional and personal obligations. Companies that recognise and accommodate these needs are more likely to retain and attract talent. The importance of providing support for family care, such as flexible hours, remote work options, and enhanced family leave policies, was underscored as a critical factor in employee satisfaction and retention.

Job creation, meanwhile, continues to be a focal point of economic recovery efforts. The pandemic-induced recession prompted substantial job losses, but recent trends suggest a positive trajectory. The demand for certain job roles has surged, particularly in healthcare, technology, and logistics. Healthcare professionals, for instance, have seen a marked increase in demand due to ongoing public health concerns and an ageing population. The tech industry, driven by the need for digital transformation, continues to grow, creating jobs in software development, cybersecurity, and data analysis. Logistics and e-commerce have also boomed, with companies investing heavily in warehousing and distribution infrastructure to meet the higher consumer demand for online shopping. Overall, the employment landscape in the US is marked by a delicate balance of adapting to new work preferences, addressing the challenges posed by an ageing workforce, and capitalising on job creation opportunities in emerging sectors. Policymakers, employers, and employees alike must navigate these trends thoughtfully to foster a resilient and dynamic workforce capable of thriving in a post-pandemic world. As we move forward, the ability to adapt to these evolving trends will determine the success and stability of the job market in the coming years.